Bayer AG's annual press conference to discuss its performance in 2021, a year that saw substantial growth and a strengthening of the pharma pipeline, has unsurprisingly been dominated by Russia's invasion of Ukraine and the impact it is already having on the German group's business.
CEO Werner Baumann began by saying that "we too are certainly shocked by the events of the past few days and are very concerned about the situation of the Ukrainian people
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?